MedPath

Effect of Shilapravanga Special in Erectile Dysfunctio

Phase 2
Conditions
Health Condition 1: N529- Male erectile dysfunction, unspecified
Registration Number
CTRI/2022/10/046858
Lead Sponsor
M/S Shree Dhootpapeshwar Limited, Mumbai
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients fulfilling the Diagnostic criteria for a minimum duration of 6 months

2. ED associated with or without PE

3. Willing and able to give informed consent

4. Willingness and ability to comply with study requirements

Exclusion Criteria

1. Known cases of uncontrolled DM and HTN

2. Known cases of BPH

3. Known cases of other major systematic disorders which interfere with the treatment

4. Diagnosed case of Peyronie’s disease or other anatomical defects

5. Known cases of congenital genitalia anomalies

6. Known case of STD

7. Subjects on anti-psychotics and nitrates

8. Participation of subjects in other studies or receipt of other investigational drugs

within 15 days prior to baseline

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath